Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fluorescence nanoparticle tracking analysis (fl-NTA) allows for accurate sizing, counting, and phenotyping of extracellular vesicles (EV). Here, we present two protocols for the analysis of EVs using fl-NTA, highlighting the potential pitfalls and challenges. The first protocol utilizes CellMask Orange™ (CMO) as a general membrane marker to label EVs derived from plasma. The second protocol describes the use of a Qdot-conjugated antibody to identify syncytiotrophoblast (STB)-derived EVs. "Standard" preparations of STB-derived EVs enriched for either microvesicles (STBMV) or exosomes (STBEX), containing a known amount of EV positive for the STB specific antigen placental alkaline phosphatase (PLAP), were also used to optimize fl-NTA camera settings.

More information Original publication

DOI

10.1007/978-1-4939-7253-1_13

Type

Journal article

Publication Date

2017-01-01T00:00:00+00:00

Volume

1660

Pages

153 - 173

Total pages

20

Keywords

Exosomes, Extracellular vesicles, Fluorescence nanoparticle tracking analysis, Microvesicles, Quantum dots, Antibodies, Cell-Derived Microparticles, Exosomes, Extracellular Vesicles, Nanoparticles, Quantum Dots, Spectrometry, Fluorescence, Trophoblasts